The silencing of PI3K p110alpha greatly decreased VEGF expression, an angiogenesis marker, impeding ovarian tumor growth and angiogenesis by targeting hypoxia-inducible factor 1 alpha in both ovarian cancer cells and tumor tissues [60,61]. This evidence concerns the gene VEGFA and ovarian cancer.